missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PI 3-Kinase p110 beta/PIK3CB Antibody (5A9), Novus Biologicals™
  7. 30037465

PI 3-Kinase p110 beta/PIK3CB Antibody (5A9), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-26383-50ul

 View more versions of this product

Product Code. 30037465

  • € 343.00 / 50µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

PI 3-Kinase p110 beta/PIK3CB Monoclonal antibody specifically detects PI 3-Kinase p110 beta/PIK3CB in Human samples. It is validated for Western Blot, ELISA, Immunoprecipitation
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PI 3-Kinase p110 beta/PIK3CB
Monoclonal
Unconjugated
PBS, pH 7.4, 150mM NaCl and 50% glycerol
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Western Blot, ELISA, Immunoprecipitation
5A9
Western Blot 1:500-1:5000, ELISA, Immunoprecipitation 1:200-1:1000
P110BETA, PI3K, PI3KBETA, PIK3C1, PIK3CB phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
A synthesized peptide derived from Human PI 3-Kinase p110 beta/PIK3CB [UniProt P42338]
50 μL
Apoptosis, Cancer, Cell Cycle and Replication, mTOR Pathway
5291
Store at -20 to -70C. Avoid freeze-thaw cycles.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.